Cite
Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.
MLA
Maung, Ko, et al. “Pre-Transplant Hepatic Steatosis (Fatty Liver) Is Associated with Chronic Graft-vs-Host Disease but Not Mortality.” PLoS ONE, vol. 15, no. 9, Sept. 2020, pp. 1–13. EBSCOhost, https://doi.org/10.1371/journal.pone.0238824.
APA
Maung, K., Ramalingam, S., Chaudhry, M., Ren, Y., Jung, S.-H., Romero, K., Corbet, K., Chao, N. J., Choi, T., Diehl, A. M., Diehl, L., Gasparetto, C., Horwitz, M., Long, G. D., Lopez, R. D., Rizzieri, D. A., Sarantopoulos, S., Sullivan, K. M., Bashir, M. R., & Sung, A. D. (2020). Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality. PLoS ONE, 15(9), 1–13. https://doi.org/10.1371/journal.pone.0238824
Chicago
Maung, Ko, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, et al. 2020. “Pre-Transplant Hepatic Steatosis (Fatty Liver) Is Associated with Chronic Graft-vs-Host Disease but Not Mortality.” PLoS ONE 15 (9): 1–13. doi:10.1371/journal.pone.0238824.